L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 6.88 NOK 0.88% Market Closed
Market Cap: 341.3m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Lytix Biopharma AS
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lytix Biopharma AS
Revenue Peer Comparison

Comparables:
HBC
B
BGBIO
AZT
N
NYKD
T
TRMED

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
L
Lytix Biopharma AS
OSE:LYTIX
Revenue
kr4m
CAGR 3-Years
N/A
CAGR 5-Years
64%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Revenue
kr221.9m
CAGR 3-Years
41%
CAGR 5-Years
30%
CAGR 10-Years
14%
B
Bergenbio ASA
OSE:BGBIO
Revenue
kr521k
CAGR 3-Years
-5%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Revenue
kr116m
CAGR 3-Years
4%
CAGR 5-Years
10%
CAGR 10-Years
17%
N
Nykode Therapeutics ASA
OSE:NYKD
Revenue
$6.1m
CAGR 3-Years
-70%
CAGR 5-Years
229%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Revenue
kr0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Lytix Biopharma AS's Revenue?
Revenue
4m NOK

Based on the financial report for Dec 31, 2023, Lytix Biopharma AS's Revenue amounts to 4m NOK.

What is Lytix Biopharma AS's Revenue growth rate?
Revenue CAGR 5Y
64%

Over the last year, the Revenue growth was -64%.

Back to Top